Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisMorrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2019Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A novel instrument to quantify organ damage in systemic sclerosisFerdowsi, N.; Huq, M.; Stevens, W.; Hudson, M.; Wang, M.; Tay, T.; Burchell, J.L.; Mancuso, S.; Rabusa, C.; Sundararajan, V.; Prior, D.; Proudman, S.M.; Baron, M.; Nikpour, M.
2021Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patientsLee, A.; Patterson, K.A.; Tan, D.J.; Wilson, M.E.; Proudman, S.M.; Stevens, W.; Nikpour, M.; Sahhar, J.; Ngian, G.-S.; Roddy, J.; Roberts-Thomson, P.J.; Walker, J.G.
2023Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.Fairley, J.L.; Hansen, D.; Ross, L.; Proudman, S.; Sahhar, J.; Ngian, G.-S.; Walker, J.; Host, L.V.; Morrisroe, K.; Apostolopoulous, D.; Ferdowsi, N.; Wilson, M.; Tabesh, M.; Stevens, W.; Nikpour, M.; Australian Scleroderma Interest Group,
2022Evaluation of patient and physician assessments of gastrointestinal disease activity in systemic sclerosisRoss, L.; Proudman, S.; Walker, J.; Stevens, W.; Ferdowsi, N.; Quinlivan, A.; Morrisroe, K.; Baron, M.; Nikpour, M.
2022Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survivalMorrisroe, K.; Hansen, D.; Stevens, W.; Sahhar, J.; Ngian, G.S.; Hill, C.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.
2014An immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3Zochling, J.; Newell, F.; Charlesworth, J.; Leo, P.; Stankovich, J.; Cortes, A.; Zhou, Y.; Stevens, W.; Sahhar, J.; Roddy, J.; Nash, P.; Tymms, K.; Rischmueller, M.; Lester, S.; Proudman, S.; Brown, M.
2014Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort studyOsthoff, M.; Ngian, G.; Dean, M.; Nikpour, M.; Stevens, W.; Proudman, S.; Eisen, D.; Sahhar, J.
2012Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosisNgian, G.; Sahhar, J.; Proudman, S.; Stevens, W.; Wicks, I.; Van Doornum, S.
2011Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohortNikpour, M.; Hissaria, P.; Byron, J.; Sahhar, J.; Micallef, M.; Paspaliaris, W.; Roddy, J.; Nash, P.; Sturgess, A.; Proudman, S.; Stevens, W.